The impact of new drugs for breast and ovarian cancer on the occurrence of therapy-related myeloid neoplasms: Understanding the baseline incidence.

The impact of new drugs for breast and ovarian cancer on the occurrence of therapy-related myeloid neoplasms: Understanding the baseline incidence. Gynecol Oncol. 2018 Nov;151(2):187-189 Authors: Sella T, Stone RM PMID: 30384959 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30384959?dopt=Abstract

Source: Gynecologic Oncology - November 1, 2018 Category: Cancer & Oncology Authors: Sella T, Stone RM Tags: Gynecol Oncol Source Type: research

More News: Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries